Hemoglobin targets for the anemia in patients with dialysis-dependent chronic kidney disease: a meta-analysis of randomized, controlled trials-Reference-Cited by-同舟云学术

Hemoglobin targets for the anemia in patients with dialysis-dependent chronic kidney disease: a meta-analysis of randomized, controlled trials

Published:2018-10-15 Issue:1 Volume:40 Page:671-679
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Ye Yuqiu¹,Liu Hongyong²,Chen Yanbing³,Zhang Yunqiang²,Li Shaomin¹,Hu Wentao¹,Yang Rongqian⁴,Zhang Zhesi⁴,Lv Linsheng⁵,Liu Xun¹²

Affiliation:

1. Department of Nephrology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;

2. Division of Nephrology, Yuedong Hospital, The Third Affiliated Hospital of Sun Yat-sen University, Meizhou, China;

3. Medical Genetic Center, Guangdong Women and Children Hospital, Guangzhou, China;

4. Department of Biomedical Engineering, South China University of Technology, Guangzhou, China;

5. Operation Room, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Funder

National Natural Science Foundation of China

Third Affiliated Hospital of Sun Yat-Sen University, Clinical Research Program

Fundamental Research Funds for the Central Universities

Ministry of Science & Technology of China

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2018.1532909

Reference42 articles.

1. Bethesda M. USRDS annual data report: Epidemiology of kidney disease in the United States. United States Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2014:188–210.

2. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency

3. Association of anemia with outcomes in men with moderate and severe chronic kidney disease

4. The epidemiology and control of anaemia among pre-ESRD patients with chronic kidney disease

5. What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level?

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lactoferrin: A Promising New Player in Treatment of Iron Deficiency Anemia in Patients on Regular Hemodialysis: A Randomized Controlled Trial;Saudi Journal of Kidney Diseases and Transplantation;2023

2. Analysis of eye conjuctive images to predict HB-level using multivariate linear regression (MLR) and K-means clustering;INTERNATIONAL CONFERENCE ON SCIENCE, ENGINEERING, AND TECHNOLOGY 2022: Conference Proceedings;2023

3. Chinese Clinical Practice Guideline for the Management of “CKD-PeriDialysis”-the Periods Prior to and in the Early-Stage of Initial Dialysis;Kidney International Reports;2022-12

4. Association between haemoglobin concentration and intradialytic hypotension in patients undergoing maintenance haemodialysis: a retrospective cohort study;BMJ Open;2022-08

5. The Possibilities of Chronic Renal Failure Patients Contracting Occult Hepatitis B Virus Infection, Sudan;Advances in Microbiology;2022